200
Views
7
CrossRef citations to date
0
Altmetric
Review

Where is the future of cardiac lead extraction heading?

, , , , , , , & show all
Pages 1197-1203 | Received 15 May 2016, Accepted 02 Aug 2016, Published online: 29 Aug 2016

References

  • Hauser RG, Katsiyiannis WT, Gornick CC, et al. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pace- maker lead extraction. Europace. 2010;12:395–401.
  • Kurtz SM, Ochoa JA, Lau E, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993–2006. Pacing Clin Electrophysiol. 2010;33:705–711.
  • Mond HG, Irwin M, Ector H, et al. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2005: an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol. 2008;31:1202–1212.
  • Uslan DZ, Tleyjeh IM, Baddour LM, et al. Temporal trends in permanent pacemaker implantation: a population study. Am Heart J. 2008;155:896–903.
  • Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Eng J Med. 2008;359:2245–2253.
  • Bardy GH, Lee KL, Mark DB, et al. Sudden cardiac death in heart failure trial (SCD-HeFT). Amiodarone or an implantable defibrillator for congestive heart failure. N Eng J Med. 2005;352:225–237.
  • Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883.
  • Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.
  • Wilkoff B. ICDs: dealing with less than perfect. J Cardiovasc Electrophysiol. 2005;16:796–797.
  • Hauser RG, Kallinnen L, Almquist A, et al. Early failure of a small-diameter high- voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2007;4:892–896.
  • Camm J, Nisam S. Implantable cardioverter-defibrillator utilization. Europace. 2011 Mar;13(3):448.
  • Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33:414–419.
  • Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999. Am Heart J. 2004;147:582–586.
  • Kleemann T, Becker T, Doenges K, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474–2480.
  • Dorwarth U, Frey B, Dugas M, et al. Transvenous defi- brillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol. 2003;14:38–43.
  • Ellenbogen KA, Wood MA, Shepard RK, et al. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73–80.
  • Luria D, Glikson M, Brady PA, et al. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol. 2001;87:901–904.
  • Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108:2015–2031.
  • Uslan DZ, Sohail MR, St Sauver JL, et al. Per- manent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167:669–675.
  • Greenspon AJ, Patel JD, Lau E, et al. 16-Yeartrendsin the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58:1001–1006.
  • Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48:590–591.
  • Bongiorni MG, Marinskis G, Lip GY, et al. How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey. Europace. 2012;14:1666–1669.
  • Le KY, Sohail MR, Friedman PA, et al. Mayo cardiovascular infections study group. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011;8:1678–1685.
  • Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: heart rhythm society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6:1085–1104.
  • Wilson DG, Yue A, Morgan JM, et al. Strategies to reduce infections during the cardiac implantable electronic device implant: a time to name and shame. Europace. 2015;17:511–513.
  • Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery EACTS, the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 21;36(44):3075–3128.
  • Nof E, Epstein LM. Complications of cardiac implants: handling device infections. Eur Heart J. 2013;34(3):229–236.
  • Swerdlow CD, Kalahasty G, Ellenbogen KA. Implantable cardiac defibrillator lead failure and management. J Am Coll Cardiol. 2016 Mar 22;67(11):1358–1368.
  • Eckstein J, Koller MT, Zabel M, et al. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation. 2008;117(21):2727–2733.
  • Kleemann T, Becker T, Doenges K, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115(19):2474–2480.
  • Maisel WH, Kramer DB. Implantable cardioverter-defibrillator lead performance. Circulation. 2008;117(21):2721–2723.
  • Liu J, Brumberg G, Rattan R, et al. Class I recall of defibrillator leads: a comparison of the sprint fidelis and riata families. Heart Rhythm. 2012;9(8):1251–1255.
  • Rijal S, Shah RU, Saba S. Extracting versus abandoning sterile pacemaker and defibrillator leads. Am J Cardiol. 2015;115:1107–1110.
  • Poole JE, Gleva MJ, Mela T, et al., REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010 Oct 19;122(16):1553–1561.
  • Uslan DZ, Gleva MJ, Warren DK, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin Electrophysiol. 2012;35(1):81–87.
  • Segreti L, Di Cori A, Soldati E, et al. Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction. Heart Rhythm. 2014;11(12):2196–2201.
  • Bongiorni MG, Segreti L, Di Cori A, et al. Safety and efficacy of internal transjugular approach for transvenous extraction of implantable cardioverter defibrillator leads. Europace. 2014;16(9):1356–1362.
  • Bongiorni MG, Di Cori A, Segreti L, et al. Transvenous extraction profile of riata leads: procedural outcomes and technical complexity of mechanical removal. Heart Rhythm. 2015;12(3):580–587.
  • Byrd CL, Wilkoff BL, Love CJ, et al. Clinical study of the laser sheath for lead extraction: the total experience in the United States. Pacing Clin Electrophysiol. 2002;25:804–808.
  • Kay GN, Brinker JA, Kawanishi DT, et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the accufix multicenter clinical study and worldwide registry. Circulation. 1999;100:2344–2352.
  • Agarwal SK, Kamireddy S, Nemec J, et al. Predictors of complications of endovascular chronic lead extractions from pacemakers and defibrillators: a single-operator experience. J Cardiovasc Electrophysiol. 2009;20:171–175.
  • Roux JF, Page P, Dubuc M, et al. Laser lead extraction: predictors of success and complications. Pacing Clin Electrophysiol. 2007;30:214–220.
  • Di Cori A, Bongiorni MG, Soldati E. Learning while extracting: ‘pacing’ lessons from the world of lead extraction. Expert Rev Cardiovasc Ther. 2013 Oct;11(10):1275–1276.
  • Segreti L, Di Cori A, Zucchelli G, et al. A questionable indication for ICD extraction after successful VT ablation. JAFIB. 2015;7:53–61.
  • Mond HG, Grenz D. Implantable transvenous pacing leads: the shape of things to come. Pacing Clin Electrophysiol. 2004;27(6 Pt 2):887–893.
  • Smith HJ, Fearnot NE, Byrd CL, et al. Five-years experience with intravascular lead extraction. U.S. lead extraction database. Pacing Clin Electrophysiol. 1994;17(11 Pt 2):2016–2020.
  • Mono HG, Stokes KB. The electrode-tissue interface: the revolutionary role of steroid elution. Pacing Clin Electrophysiol. 1992;15(1):95–107.
  • Di Cori A, Bongiorni MG, Zucchelli G, et al. Short-term extraction profile of cardiac pacing leads with hybrid silicone-polyurethane insulator: a pilot study. Int J Cardiol. 2013. 9. 168(4):4432–4433.
  • Epstein LM, Love CJ, Wilkoff BL, et al. Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. J Am Coll Cardiol. 2013;61(9):987–989.
  • Di Cori A, Bongiorni MG, Zucchelli G, et al. Transvenous extraction performance of expanded polytetrafluoroethylene covered ICD leads in comparison to traditional ICD leads in humans. Pacing Clin Electrophysiol. 2010;33(11):1376–1381.
  • Kohut AR, Grammes J, Schulze CM, et al. Percutaneous extraction of ePTFE-coated ICD leads: a single center comparative experience. Pacing Clin Electrophysiol. 2013;36(4):444–450.
  • Bongiorni MG, Viani S, Zucchelli G, et al. Subcutaneous implantable cardiac defibrillators: indications and limitations. Curr Heart Fail Rep. 2015;12(1):79–86.
  • Ali H, Lupo P, Cappato R. The entirely subcutaneous defibrillator - A new Generation and future expectations. Arrhythm Electrophysiol Rev. 2015;4(2):116–121.
  • Weiss R, Knight BP, Gold MR, et al. Safety and efficacy of a totally subcutaneous implantable- cardioverter defibrillator. Circulation. 2013;128(9):944–953. International registry on S-ICD performance.
  • Lambiase PD, Barr C, Theuns DA, et al. Worldwide experience with a totally subcutaneous im- plantable defibrillator: early results from the EFFORTLESS investigators. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESSS- ICD registry. Eur Heart J. 2014;35(25):1657–1665.
  • Miller MA, Neuzil P, Dukkipati SR, et al. Leadless cardiac pacemakers: back to the future. J Am Coll Cardiol. 2015 8;66(10):1179–1189.
  • Auricchio A, Delnoy PP, Butter C, et al. For the collaborative study group. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: re- sults of the wireless stimulation endocardially for CRT (WiSE-CRT) study. Europace. 2014;16:681–688.
  • Reddy V, Sedivy P, Mraz T, et al. Wireless LV endocardial stimulation for cardiac resynchroni- zation: initial experience from the SELECT-LV study (abstr). Heart Rhythm. 2014;11(Suppl):S41.
  • Reddy VY, Knops RE, Sperzel J, et al. Perma- nent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129:1466–1471.
  • Knops RE, Tjong FV, Neuzil P, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol. 2015;65:1497–1504.
  • Reynolds D, Duray GZ, Omar R, et al., Micra Transcatheter Pacing Study Group. A leadless intracardiac transcatheter pacing system, N Engl J Med, 201611;374(6):533–541.
  • Ritter P, Duray GZ, Steinwender C, et al., Micra Transcatheter Pacing Study Group. Early performance of a miniaturized leadless cardiac pacemaker: the micra transcatheter pacing study, Eur Heart J, 20151;36(37):2510–2519.
  • Bongiorni MG, Segreti L, Di Cori A, et al. Retrieval of a transcatheter pacemaker in sheep after a mid-term implantation time. Heart Rhythm Case Reports. 2016;2:43–46.
  • Mulpuru SK, Hayes DL, Osborn MJ, et al. Femoral approach to lead extraction. J Cardiovasc Electrophysiol. 2015;26:357–361.
  • Bracke FA, Dekker L, van Gelder BM. The needle’s eye snare as a primary tool for pacing lead extraction. Europace. 2013;15:1007–1012.
  • Bongiorni MG, Soldati E, Zucchelli G, et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J. 2008;29:2886–2893.
  • Bongiorni MG, Segreti L, Di Cori A, et al. Safety and efficacy of internal transjugular approach for transvenous extraction of implantable cardioverter defibrillator leads. Europace. 2014;16:1356–1362.
  • Aytemir K, Yorgun H, Canpolat U, et al. Initial experience with the tightrail™ rotating mechanical dilator sheath for transvenous lead extraction. Europace. 2016;18(7):1043–1048.
  • Mazzone P, Tsiachris D, Marzi A, et al. Advanced techniques for chronic lead extraction: heading from the laser towards the evolution system. Europace. 2013;15(12):1771–1776.
  • Oto A, Aytemir K, Canpolat U, et al. Evolution in transvenous extraction of pacemaker and implantable cardioverter defibrillator leads using a mechanical dilator sheath. Pacing Clin Electrophysiol. 2012;35(7):834–840.
  • Diemberger I, Mazzotti A, Giulia MB, et al. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction. Expert Rev Med Devices. 2013 Jul;10(4):551–573.
  • Hauser RG, Katsiyiannis WT, Gornick CG, et al. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction. Europace. 2010;12:395–401.
  • Epstein LM, Love CJ, Wilkoff BL, et al. Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. J Am Coll Cardiol. 2013 Mar 5;61(9):987–989.
  • Bracke FA, Meijer A, Van Gelder B. Learning curve characteristics of pacing lead extraction with a laser sheath. Pacing Clin Electrophysiol. 1998;21:2309–2313.
  • Smith HJ, Fearnot NE, Byrd CL, et al. Intravascular extraction of chronic pacing leads: the effect of physician experience (abstract). Pacing Clin Electrophysiol. 1992;15:513.
  • Ghosh N, Yee R, Klein G, et al. Laser lead extraction. Is there a learning curve. Pacing Clin Electrophysiol. 2005;28:180–184.
  • Wazni O, Epstein LM, Carrillo RG, et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol. 2010. 9. 55(6):579–586.
  • Neuzil P, Taborsky M, Rezek Z, et al. Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: results of a randomized trial. Europace. 2007;9:98–104.
  • Deharo JC, Bongiorni MG, Rozkovec A, et al. European Heart Rhythm Association. Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper. Europace. 2012 Jan;14(1):124–134.
  • Wazni O, Wilkoff BL. Considerations for cardiac device lead extraction. Nat Review Cardiol. 2016;13:221–229.
  • Bongiorni MG, Romano SL, Kennergren C, et al. Lead extraction and registry experiences in Europe. Card Electrophysiol Clin. 2014;6:335–344.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.